Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations
European Journal of Clinical Pharmacology, Volume 69, No. SUPPL. 1, Year 2013
Notification
URL copied to clipboard!
Description
Purpose: In September 2012 an interactive course on the "Interface Management of Pharmacotherapy" was organized by the Stockholm Drug and Therapeutics Committee in cooperation with Department of Clinical Pharmacology at Karolinska Institutet and at Karolinska University Hospital in Stockholm, Sweden, in collaboration with the WHO. The basis for the course was the "Stockholm model" for the rational use of medicines but also contained presentations about successful models in interface management of pharmacotherapy in other European countries. Methods: The "Stockholm model " consists of 8 components: 1) Independent Drug and Therapeutics Committee with key role for respected drug experts with policy for "interest of conflicts", 2) The "Wise List", recommendations of medicines jointly for primary and hospital care, 3) Communication strategy with continuous medical education, 4) Systematic introduction of new expensive medicines, 5) E-pharmacological support at "point of care", 6) Methods and tools for follow-up of medicines use, 7) Medicines policy strategy and 8) Operative resources. Results: The course highlighted the importance of efficient and targeted communication of drug recommendations building on trust among prescribers and patients for the guidelines to achieve high adherence. Trust is achieved by independent Drug and Therapeutics Committees with a key role for respected experts and a strict policy for "conflicts of interest". Representations of GPs are also crucial for successful implementation, being the link between evidence based medicine and practice. Conclusion: The successful models in Scotland and in Stockholm as well as the ongoing work in Catalonia were considered as examples of multifaceted approaches to improve the quality of medicine use across primary and hospital care. © Springer-Verlag 2013.
Authors & Co-Authors
Laing, Richard Ogilvie
Unknown Affiliation
Melien, Øyvind
Norway, Oslo
Norwegian Directorate of Health
Malmström, Rickard E.
Sweden, Stockholm
Karolinska Institutet
Vogler, Sabine
Austria, Vienna
Gesundheit Österreich Gmbh
Godman, Brian Barr
Sweden, Stockholm
Karolinska Institutet
United Kingdom, Glasgow
University of Strathclyde
Gustafsson, Lars L.
Sweden, Stockholm
Karolinska Institutet
Statistics
Citations: 71
Authors: 6
Affiliations: 6
Identifiers
Doi:
10.1007/s00228-013-1497-5
ISSN:
00316970
Research Areas
Health System And Policy
Study Design
Cohort Study